293 results
Page 3 of 15
8-K
EX-99.1
l0rugxt3 nladatdeb0
5 Aug 21
Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates
4:01pm
8-K
EX-99.1
7oc2l1a
12 Jul 21
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
11:13am
8-K
EX-10.1
qjfc33msjwnuhqsv
12 Jul 21
Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
11:13am
8-K
EX-99.1
piiy3wixah5l
10 Jun 21
Cardiff Oncology Announces the Appointment of Two New Independent Members to its Board of Directors
4:07pm
8-K
EX-99.1
2zwvym3 vvwsl
8 Jun 21
Cardiff Oncology Announces First Patient Dosed in a Phase 2 Trial of Onvansertib in Combination with Irinotecan and 5-FU in Pancreatic Cancer
8:41am
8-K
EX-99.1
50lysyvc
1 Jun 21
Regulation FD Disclosure
10:52am
8-K
EX-99.1
cpxcs4suf0 hziie
6 May 21
Cardiff Oncology Announces First Quarter 2021 Results and Recent Highlights
4:01pm
8-K
EX-99.3
ingxhndw1zbqngg9
12 Apr 21
Key Opinion Leader Webinar Onvansertib for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer
8:33am
8-K
EX-99.4
19sqx
12 Apr 21
Key Opinion Leader Webinar Onvansertib for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer
8:33am
8-K
EX-99.2
q3bbe93f1 2r
12 Apr 21
Key Opinion Leader Webinar Onvansertib for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer
8:33am
8-K
EX-99.1
hc0uez2 skfr9mp
12 Apr 21
Key Opinion Leader Webinar Onvansertib for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer
8:33am
S-3ASR
g7t128kb 3mtllc5h
12 Mar 21
Automatic shelf registration
4:10pm
S-3ASR
EX-4.3
cksar0yqh
12 Mar 21
Automatic shelf registration
4:10pm
S-3ASR
EX-4.4
kt6v 0txmeuglgtiqw75
12 Mar 21
Automatic shelf registration
4:10pm
8-K
EX-99.1
hu0cr
25 Feb 21
Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights
4:02pm